Fig. 1.
Treatment action on proliferative phase of HepG2 cells. a Experimental scheme of HepG2 treatments. b Growth curve and viability determination: treatment with LC, F or LCF not altered HepG2 proliferative potential. Viability graph showed the absence of cell mortality in all treatment conditions. For growth curve and viability, a two-way ANOVA test followed by Tukey’s multiple comparison test was performed